9237 related articles for article (PubMed ID: 1980967)
1. Production, circulation, and excretion of melanin-related metabolites in B16 melanoma-bearing mice.
Wakamatsu K; Ito S; Fujita K
Acta Derm Venereol; 1990; 70(5):367-72. PubMed ID: 1980967
[TBL] [Abstract][Full Text] [Related]
2. Melanin-related metabolites in urine of B16 melanoma-bearing mice.
Wakamatsu K; Ito S; Fujita K
Acta Derm Venereol; 1988; 68(5):385-9. PubMed ID: 2461020
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of melanin-related metabolites as markers of melanoma progression.
Horikoshi T; Ito S; Wakamatsu K; Onodera H; Eguchi H
Cancer; 1994 Feb; 73(3):629-36. PubMed ID: 8299084
[TBL] [Abstract][Full Text] [Related]
4. Correlation between urinary melanin-related metabolites and tumour weight in melanoma-bearing mice.
Ito S; Wakamatsu K; Inoue S; Fujita K
Acta Derm Venereol; 1989; 69(5):380-4. PubMed ID: 2572100
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of melanin-related metabolites as markers of solar ultraviolet-B radiation.
Wakamatsu K; Ito S
Pigment Cell Res; 2006 Oct; 19(5):460-4. PubMed ID: 16965276
[TBL] [Abstract][Full Text] [Related]
6. Determination of eumelanin in human urine.
Wakamatsu K; Takasaki A; Kågedal B; Kageshita T; Ito S
Pigment Cell Res; 2006 Apr; 19(2):163-9. PubMed ID: 16524432
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in children.
Meyerhöffer S; Lindberg Z; Häger A; Kågedal B; Rosdahl I
Acta Derm Venereol; 1998 Jan; 78(1):31-5. PubMed ID: 9498023
[TBL] [Abstract][Full Text] [Related]
8. High plasma level of a eumelanin precursor, 6-hydroxy-5-methoxyindole-2-carboxylic acid as a prognostic marker for malignant melanoma.
Hara H; Walsh N; Yamada K; Jimbow K
J Invest Dermatol; 1994 Apr; 102(4):501-5. PubMed ID: 8151128
[TBL] [Abstract][Full Text] [Related]
9. Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid, biochemical markers of melanoma progression.
Wakamatsu K; Ito S; Horikoshi T
Melanoma Res; 1991; 1(2):141-7. PubMed ID: 1823626
[TBL] [Abstract][Full Text] [Related]
10. Serum 5-S-cysteinyldopa (5-S-CD) as a marker of melanoma progression.
Horikoshi T; Ito S
J Dermatol; 1992 Nov; 19(11):809-13. PubMed ID: 1293168
[TBL] [Abstract][Full Text] [Related]
11. A method for measuring serum levels of melanin-associated indole metabolites using LC-MS/MS and its application to malignant melanoma.
Takiwaki M; Umemura H; Kikutani Y; Fukuzawa S; Abe K; Fujino K; Sugihara S; Tachibana K; Morizane S; Satoh M; Nakayama T; Yamasaki O
Clin Chim Acta; 2024 Apr; 557():117873. PubMed ID: 38493943
[TBL] [Abstract][Full Text] [Related]
12. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
Yamada K; Walsh N; Hara H; Jimbow K; Chen H; Ito S
Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
[TBL] [Abstract][Full Text] [Related]
13. S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma.
Kärnell R; von Schoultz E; Hansson LO; Nilsson B; Arstrand K; Kågedal B
Melanoma Res; 1997 Oct; 7(5):393-9. PubMed ID: 9429222
[TBL] [Abstract][Full Text] [Related]
14. Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma: a preliminary report.
Pavel S; Muskiet FA
Cancer Detect Prev; 1983; 6(1-2):311-6. PubMed ID: 6883388
[TBL] [Abstract][Full Text] [Related]
15. Seasonal variation in serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in healthy Japanese.
Wakamatsu K; Ito S
Pigment Cell Res; 1995 Jun; 8(3):132-4. PubMed ID: 7567788
[TBL] [Abstract][Full Text] [Related]
16. Comparison of phaeomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients.
Wakamatsu K; Yokochi M; Naito A; Kageshita T; Ito S
Melanoma Res; 2003 Aug; 13(4):357-63. PubMed ID: 12883361
[TBL] [Abstract][Full Text] [Related]
17. The stability of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in human urine.
Kågedal B; Lenner L; Arstrand K; Hansson C
Pigment Cell Res; 1992; Suppl 2():304-7. PubMed ID: 1409435
[TBL] [Abstract][Full Text] [Related]
18. [Eumelanin and pheomelanin contents in hairs of healthy Japanese and patients with oculocutaneous albinism, and 5-S-cysteinyldopa and 5-hydroxy-6-methoxyindole-2-carboxylic acid levels in urine of oculocutaneous albinism].
Saito N; Morishima T
Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):853-61. PubMed ID: 2122048
[TBL] [Abstract][Full Text] [Related]
19. Melanin-related metabolites as markers of the skin pigmentary system.
Westerhof W; Pavel S; Kammeyer A; Beusenberg FD; Cormane R
J Invest Dermatol; 1987 Jul; 89(1):78-81. PubMed ID: 3598203
[TBL] [Abstract][Full Text] [Related]
20. Plasma 5-S-cysteinyldopa correlates with tumor size in melanoma-bearing mice.
Hu F; Woodward WR; Peterson LL
J Invest Dermatol; 1988 Feb; 90(2):149-51. PubMed ID: 3123557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
